Hence, it is suggested that a potential mechanism to block the development of inflammation, by the effective medicines that used for treating mastitis, is inhibiting TNF signaling pathway through reducing the secretion of TNF (Wu et al., 2019). The gene discussed is TNF; the disease is mastitis.